Acid aspiration provokes the pneumonia caused by multidrug-resistant Acinetobacter baumannii in BALB/c mice

Shyh-Ren Chiang1, Hung-Jen Tang, Chung-Hua Chen

  • 1Department of Internal Medicine, Chi Mei Medical Center, 901, Chung-Hwa Road, Yung-Kang Dist., Tainan City, Taiwan.

Abstract

Insights

Acid aspiration triggers multidrug-resistant Acinetobacter baumannii (MDRAB) pneumonia. This lung injury and bacterial infection synergistically worsen outcomes in mice.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Critical Care

Background:

  • Acid aspiration is a common complication in critically ill patients.
  • Multidrug-resistant Acinetobacter baumannii (MDRAB) is a significant nosocomial pathogen.

Purpose of the Study:

  • To investigate if acid aspiration can precipitate the development of MDRAB pneumonia.
  • To explore the synergistic effects between acid aspiration and MDRAB infection on lung injury.

Main Methods:

  • Mice were intratracheally inoculated with hydrochloric acid and/or MDRAB (Ab396 strain).
  • Evaluated outcomes included bacterial load, lung permeability, cytokine levels (TNF-α), histopathology, and survival rates.

Main Results:

  • Mice exposed to both acid and MDRAB developed severe pneumonia with higher bacterial loads and lung leakage.
  • A significant synergistic effect was observed between acid aspiration and MDRAB infection, leading to increased lung injury.
  • Lower levels of TNF-α were noted in the group with both acid and MDRAB exposure.

Conclusions:

  • Acid aspiration can provoke secondary MDRAB pneumonia.
  • The combination of acid aspiration and MDRAB infection results in a detrimental synergistic effect on lung injury and survival.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: